Arachidonic acid uptake by human platelets is mediated by CD36

Platelets

Volumn 7, Issue 5-6, 1996, Pages 291-295

  Dutta Roy, A K ^a   Gordon, M J ^a   Campbell, F M ^a   Crosbie, L C ^a  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CARBON 14; CD36 ANTIGEN; COLLAGEN; MONOCLONAL ANTIBODY; THROMBOXANE A2;

ARTICLE; CONTROLLED STUDY; FATTY ACID TRANSPORT; HUMAN; HUMAN CELL; ICOSANOID METABOLISM; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION;

EID: 0030462449     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.3109/09537109609023591     Document Type: Article

References (27)

1. Greenwalt DE, Lipskey RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA. Membrane glycoprotein CD36: a review of its role in adherence, signal transduction, and transfusion medicine. Blood 1992; 80: 1105-15.
2. Michelson AD, Wencel-Drake JD, Kestin AS, Barnard MR. Platelet activation results in a redistribution of glycoprotein IV (CD36). Arterioscler Thromb 1994; 14: 1193-201.
3. Greenwalt DE, Scheck SH, Rhinehart T. Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet, J Clin Invest 1995; 96: 1382-8.
4. Endemann GI, Stanton IW, Madden KS, Bryant CM, White RT, Protter AA. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 1993; 268: 11811-6.
5. Abumrad NA, El-Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA. Cloning of a rat adipocyte membrane-protein implicated in binding or transport of long chain fatty acids that is induced during preadipocyte differentiation: Homology with human CD36. J Biol Chem 1993; 268: 17665-8.
6. Spitsberg VL, Mattashvili E, Grewit RC. Association and coexpression of fatty acid binding protein and glycoprotein in the bovine mammary gland. Eur J Biochem 1995; 230: 872-8.
7. Dutta-Roy AK. Insulin mediated processes in platelets, monocytes/macrophages and erythrocytes: Effects of essential fatty acid metabolism. Prost Leuk Essntl Fatty Acids 1994; 51: 385-9.
8. Dutta-Roy AK, Ray TK, Sinha AK. Prostacyclin stimulation of the activation of blood coagulation factor X by platelets. Science 12986; 231: 385-8.
9. 2 - its generation and role in platelet activation. Prog Lipid Res 1989; 28: 273-301.
10. 1/Prostacyclin receptors of human blood platelets. J Biol. Chem 1987; 262: 12685-91.
11. Perez C, Ramiro JM, Campillo JE. Increased arachidonic acid uptake by platelets from insulin-dependent diabetics and diabetic rats. Diabet Res Clin Prac 1989; 7: 69-77.
12. Thibert V, Bellucci S, Cristofari M, Gluckman E, Legrand C. Increased platelet CD36 constitutes a common marker in myleo-proliferative disorders. Br J Haematol 1995; 91: 618-24.
13. Mikhailidis DP, Jeremy JY, Barradas MA, Dandona P. Increased arachidonic acid incorporation into platelet phospholipids in type-2 (non-insulin-dependent) diabetes. Diabetologia 1984; 27: 242.
14. Campbell FM, Gordon MJ, Dutta-Roy AK. Plasma membrane fatty acid binding protein from human placenta: Identification and characterization. Biochem Biophys Res Commun 1995; 209: 1011-17.
15. Campbell FM, Gordon MJ, Dutta-Roy AK. Preferential uptake of long chain polyunsaturated fatty acids by isolated human placental membranes. Mol Cell Biochem 1996; 155: 77-83.
16. Aiken ML, Ginsberg MH, Byers-Ward V, Plow EF. Effects of OKM5, a monoclonal antibody to glycoprotein IV, on platelet aggregation and thrombospondin surface expression. Blood 1990; 76: 2501-9.
17. a platelets lack detectable GPIV (CD36). Blood 1990; 76: 1698-703.
18. a, involved in the refractoriness of HLA-matched platelet transfusion. Vox Sand 1989; 57: 213-20.
19. Yamamoto N, Akamatsu N, Yamazaki H., Tanoue K. Normal aggregations of glycoprotein IV (CD36)-deficient platelets from seven healthy Japanese donors. Br J Haematol 1992; 81: 86-9.
20. Dizricart M, Tandon NN, Gomezoritz G, Carretero M, Escolar G, Ordinas A, Jamieson GA. Antibodies to CD36 (GPIV) inhibit platelet-adhesion to subendothelial surfaces under flow conditions. Arterioscler Thromb Vase Biol 1996; 16: 883-8.
21. Beer JH, Rabaglio M, Berchthold P, von Felten A, Clemetson KJ, Tsakiris DA, Kehrel B, Brandenberger S. Autoantibodies against the platelet glycoproteins (GP) IIb/IIIa, Ia/IIa, and IV and partial deficiency in GPIV in a patient with bleeding disorder and a defective platelet collagen interaction. Blood 1993; 82: 820-9.
22. Aitken ML, Ginsberg MH, Byers-Ward V, Plow EF. Effects of OKM5, a monoclonal antibody to glycoprotein IV on platelet aggregation, and thrombospondin surface expression. Blood 1990; 76: 2501-9.
23. Legrand C, Pidart D, Beiso P, Tenza D. Edelman L. Interaction of monoclonal antibody to glycoprotein IV (CD36) with human platelets and its effect on platelet function. Platelets 1991; 2: 99-105.
24. Tandon NN, Kralisz U, Jamieson GA. Identification of glycoprotein IV (CD36) as a primary receptor for platelet collagen adhesion. J Biol Chem 1989; 264: 7576-83.
25. McGregor JI, Catimel B, Parmentier S, Clezardin P, Dechavanne M, Leung LIK. Rapid purification and partial characterization of human platelet glycoprotein IIIb. J Biol Chem 1989; 264: 501-6.
26. Kashiwagi H, Honda S, Tomiyama Y, Mizutani H, Take H, Honda Y, Kosugi S, Kanayama Y, Kurata Y, Matsuzawa Y. A novel polymorphism in glyucoprotein-IV (replacement of proline-90 by serine) predominates in subjects with platelet GPIV deficiency. Thromb Haemost 1993; 69: 481-4.
27. Puenete Navazo MD, Davie L, Savil J, Ren Yi, Leung LLK, McGregor JL. Identification of a domain (155-183) on CD36 implicated in the phagocytosis of apoptotic neutrophils. J Biol Chem 1996; 271: 15381-6.